Skip to main content
. 2020 Feb 6;7(6):1902312. doi: 10.1002/advs.201902312

Figure 3.

Figure 3

Several promising approaches have been adopted to decrease the off‐target activity of CRISPR/Cas systems, including decreased stem cell or plant tissue culture time, high‐quality reference genome, optimal sgRNA designing, and high‐fidelity CRISPR/Cas variants. These systems are engineered for greater precision, target specificity with no or at least much lower off‐target activity than wild‐type Cas9.